4//SEC Filing
Coen Stacy Ann 4
Accession 0001415889-24-000381
CIK 0000855654other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:51 PM ET
Size
8.9 KB
Accession
0001415889-24-000381
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
Coen Stacy Ann
Chief Business Officer
Transactions
- Award
Common Stock
2023-12-29$16.01/sh+367$5,876→ 63,507 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-12-29−30,000→ 303,465 totalExercise: $5.32Exp: 2032-02-04→ Common Stock (30,000 underlying) - Exercise/Conversion
Common Stock
2023-12-29$5.32/sh+30,000$159,600→ 63,140 total
Footnotes (3)
- [F1]These shares were purchased due to participation by the reporting individual in the ImmunoGen Employee Stock Purchase Plan (the ESPP). It pertains to the ESPP purchase period from July 1, 2023 through December 31, 2023.
- [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 3, 2023
- [F3]This option was granted on February 4, 2022 and is exercisable as to 25% on the first year anniversary of the grant and 6.25% quarterly for the subsequent three years.
Documents
Issuer
ImmunoGen, Inc.
CIK 0000855654
Entity typeother
Related Parties
1- filerCIK 0001814150
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 5:51 PM ET
- Size
- 8.9 KB